Several studies have shown that HAVCR2 is significantly upregulated in clear cell renal carcinoma [43], bladder urothelial carcinoma [44], and STAD [45] and is associated with poor prognosis in cancers. This evidence concerns the gene HAVCR2 and clear cell renal carcinoma.